Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

E2F Transcription Factor 2 (E2F2) (Middle Region) Peptide

E2F2 Reactivity: Human Host: Synthetic BP, WB, IHC
Catalog No. ABIN976079

Quick Overview for E2F Transcription Factor 2 (E2F2) (Middle Region) Peptide (ABIN976079)

Target

E2F2 (E2F Transcription Factor 2 (E2F2))

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-E2F2 antibody (Catalog #: ARP38418_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    E2F2 (E2F Transcription Factor 2 (E2F2))

    Background

    E2F2 is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F1 and E2F3, have an additional cyclin binding domain. This protein binds specifically to retinoblastoma protein pRB in a cell-cycle dependent manner, and it exhibits overall 46 % amino acid identity to E2F1.The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F1 and E2F3, have an additional cyclin binding domain. This protein binds specifically to retinoblastoma protein pRB in a cell-cycle dependent manner, and it exhibits overall 46 % amino acid identity to E2F1. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: E2F-2

    Protein Interaction Partner: E2F4,RBL2,CDC25A,CDC6,E2F1,EAPP,FHL2,GAB2,JMY,MT1G,MYBL2,PPP1R13B,RB1,RB1,RB1,RBL1,RYBP,SETD8,TP53BP2,TP53INP1,UXT,ARID3A,BCAR1,BRD2,CDK3,RB1,RYBP,SETD8,SP1,TFDP1,TFDP2,YY1,BCAR1,BRD2,FHL2,RB1,RNF144A,RYBP,SETD8,SPIB,Sp1

    Protein Size: 437

    Molecular Weight

    47 kDa

    Gene ID

    1870

    NCBI Accession

    NM_004091, NP_004082

    UniProt

    Q14209
You are here:
Chat with us!